MaxCyte to Present at Upcoming 2020 Solebury Trout Virtual Investor Conference

On April 6, 2020 MaxCyte, a global cell-based therapies and life sciences company, reported that CEO Doug Doerfler plans to present an overview of the company and provide a business update at the upcoming Solebury Trout Virtual Global Healthcare Series (Press release, MaxCyte, APR 6, 2020, View Source [SID1234556157]). During the 25-minute presentation, participants will be able to submit questions electronically with answers provided by the company on an individual basis afterwards. Details are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Date/Time: Tuesday, April 7, 2020, at 10:30 a.m. EDT
To access the presentation, please login HERE: https://78449.themediaframe.com/dataconf/productusers/solebury/mediaframe/36850/indexl.html